Skip to main content

NICHOLS & PRATT ADVISERS LLP /MA

Position in NVO — Novo Nordisk A S

CIK 1141781 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$22,899,738
+$5,248,015 QoQ
Shares Held
477,675
-0.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#91
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 8% Shared 92% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NICHOLS & PRATT ADVISERS LLP /MA holds $207,768,859 across 8 Drug Manufacturers - General names. NVO ranks #3 (11.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NVO
Novo Nordisk A S
This page
477,675 $22,899,738

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,899,738 477,675
2026-03-31 $17,651,723 480,319
2025-12-31 $24,810,359 487,625
2025-09-30 $27,799,990 500,991
2025-06-30 $33,961,704 492,056
2025-03-31 $33,422,444 481,314
2024-12-31 $41,107,151 477,879
2024-09-30 $58,131,164 488,210
2024-06-30 $70,829,728 496,215
2024-03-31 $63,753,167 496,520
2023-12-31 $51,993,969 502,600
2023-09-30 $46,293,916 509,060
2023-06-30 $41,415,532 255,920
2023-03-31 $41,055,096 257,981
2022-12-31 $35,430,251 261,787
2022-09-30 $26,125,675 262,227
2022-06-30 $29,329,712 263,212
2022-03-31 $29,280,775 263,672
2021-12-31 $29,525,664 263,622
2021-09-30 $25,336,750 263,897
2021-06-30 $22,110,420 263,942
2021-03-31 $17,783,845 263,777
2020-12-31 $18,462,192 264,312
2020-09-30 $18,406,794 265,113
2020-06-30 $17,309,964 264,355
2020-03-31 $15,997,547 265,740